Manish Sheth
Psychiatry · San Diego, CANPI 1225083272
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 406 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 406 payments — averaging $24.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$906
- Lundbeck LLC$861
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$685
- Takeda Pharmaceuticals U.S.A., Inc.$630
- plus $4K from 24 others
What the payments were for
- Food & beverage$9,895100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 68 | $1,784 |
| AbbVie(2 entities) | 57 | $1,051 |
| Otsuka America Pharmaceutical, Inc. | 46 | $906 |
| Lundbeck LLC | 40 | $861 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $685 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $630 |
| Neurocrine Biosciences, Inc. | 15 | $623 |
| Vanda Pharmaceuticals Inc. | 20 | $486 |
| Axsome Therapeutics, Inc. | 18 | $426 |
| Sunovion Pharmaceuticals Inc. | 14 | $313 |
| Indivior Inc. | 11 | $242 |
| Teva Pharmaceuticals USA, Inc. | 6 | $204 |
| Alkermes, Inc. | 9 | $191 |
| Tempus AI, Inc | 3 | $178 |
| Brainsway USA Inc | 3 | $177 |
| Corium, LLC | 7 | $170 |
| E.r. Squibb & Sons, L.L.C. | 2 | $138 |
| CSL Behring | 1 | $125 |
| Supernus Pharmaceuticals, Inc. | 5 | $106 |
| Sage Therapeutics, LLC | 1 | $106 |
| Neos Therapeutics, LP | 4 | $98 |
| Janssen Scientific Affairs, LLC | 1 | $90 |
| Merck | 3 | $67 |
| Shire North American Group Inc | 3 | $60 |
| Livanova USA, Inc. | 2 | $45 |
| Alfasigma USA, Inc. | 2 | $43 |
| Ironshore Pharmaceuticals Inc. | 2 | $37 |
| Boston Scientific | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Bausch Health US, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$369
- INGREZZA$298
- Hizentra$125
- Austedo XR$121
- COBENFY$111
- ZULRESSO$106
- Brainsway Deep TMS$106
How this compares
$9,895 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Other psychiatry in San Diego
- Jonathan MeyerSan Diego$2.3M
- Sanjai RaoSan Diego$445K
- Murray SteinSan Diego$121K
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.